Most small caps trade on a story nobody has properly checked. Fox checks it.
He covers mining and resources, biotech, healthcare and technology across the ASX and US markets, looking for companies where the next result, approval or contract could force a rethink of what the business is worth. A drill hole that changes the size of a deposit. A trial readout that de-risks a pipeline. A first big customer that turns a product into a business.
He also tracks the bigger forces moving money into these sectors, from critical minerals and supply-chain security to shifts in healthcare and tech adoption, and the small caps sitting in their path before the rest of the market notices.
The question is always the same: is the market pricing this right? Fox works through the filings, the balance sheet and the peer comps to find out, then lays out the upside, the risks and what to watch next.
Before Cashu, Fox spent years in healthtech, sizing up early-stage investments for high-net-worth investors.